Due to the constraints of the publication schedule, we ask that before submitting a query relating to the clinical content of BNF publications, you:
The email address for enquiries about clinical content is editor@bnf.org
We ask that manufacturers consult the information below before contacting the BNF editorial team. BNF editors will not discuss content with representatives of the pharmaceutical industry by telephone.
1. Deadlines for submission
To allow time for editorial processes, a cut-off date for the submission of new information and updates is set before publication. Information received after this date will be considered for the following edition. We receive increasing volumes of information immediately before each deadline and therefore recommend that you submit completed product information as soon as it is available.
We cannot confirm or guarantee any inclusion or amendment until after publication. If the launch date of a product falls significantly later than a deadline, that product will be considered for the following edition.
Generally, deadlines fall 2–3 months before publication. Please contact us at the email address below for this years deadlines.
2. Information to send
To consider listing a new product, we will initially require the following:
Pricing information: Prices in BNF publications are obtained from the NHSBS Prescription service (formerly the PPD) via the DM+D service (http://dmd.medicines.org.uk) and represent a ‘snapshot’ in time: please refer to How to Use the BNF for more information. To ensure accurate prices are reflected in the BNF, manufacturers must update product prices with the DM+D via the ‘In Demand’ service.
3. Where to send information:
The email address to send product information or related manufacturer enquiries is manufacturerinfo@bnf.org
or by post to: BNF, 1 Lambeth High Street, London, SW1 7JN
BNF publications are constructed to support healthcare professionals in making decisions about the effective and safe use of medicines; information in our publications is not designed for use by patients or members of the public. Furthermore, although the BNF aims to give the best possible advice on treatment, there are sometimes special circumstances when a healthcare professional may decide to deviate from this advice.
We regret that we are unable to comment on individual cases and we cannot enter into correspondence with patients (or their relatives). These matters are best dealt with by properly qualified healthcare professionals who are familiar with all the circumstances surrounding the case. If you have questions about medicines, we recommend you refer them to your doctor or local pharmacist.
The UK health departments distribute BNFCs to NHS hospitals, doctors, and community pharmacies.
In England, BNFCs are mailed individually to NHS doctors, pharmacists, and non-medical prescribers who have prescribing responsibility for children; contact the DH Publications Orderline on 0300 123 1002.
In Scotland, email
nss.psd-bnf@nhs.net
In Wales, contact the Business Services Centre on (01495) 332 000.
In Northern Ireland, email
ni.bnf@hscni.net
For all other enquiries relating to purchasing copies or subscribing to BNF print and digital publications: http://www.pharmpress.com/
Printed BNFs, even those that are 6-12 months old, are much in demand in many developing countries. The PharmAid scheme of the Commonwealth Pharmaceutical Association dispatches old BNFs to Commonwealth pharmacies. Old BNFs are collected annually.
For further information please go to
http://www.commonwealthpharmacy.org/about/projects/pharmaid
or email admin@commonwealthpharmacy.org